Los Angeles Capital Management
ORKA

Los Angeles Capital Management’s Oruka Therapeutics ORKA Stock Holding History

Los Angeles Capital Management’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.3K Sell
255
-464
-65% -$30.9K ﹤0.01% 1735
2026
Q1 		$35.3K Sell
719
-583
-45% -$20.3K ﹤0.01% 1576
2025
Q4 		$36.6K Buy
+1,302
New +$36.3K ﹤0.01% 1688

Other funds holding ORKA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Los Angeles Capital Management's ORKA Position: Q2 2026 in Review

Los Angeles Capital Management reduced its Oruka Therapeutics (ORKA) stake by 65% in Q2 2026, selling an estimated $30.9K and leaving 255 shares worth $24.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1735.

Los Angeles Capital Management first reported a position in ORKA in Q4 2025 and has held it in 3 quarters since. The position peaked at $36.6K in Q4 2025. 255 funds tracked by Wall St. Rank hold ORKA as of Q2 2026.

  • Los Angeles Capital Management held 255 shares of Oruka Therapeutics worth $24.3K as of Q2 2026.
  • Los Angeles Capital Management sold 464 Oruka Therapeutics shares in Q2 2026, an estimated $30.9K.
  • Oruka Therapeutics made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q2 2026, its #1735 holding.
  • Los Angeles Capital Management first reported a position in Oruka Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • Los Angeles Capital Management's Oruka Therapeutics position peaked at $36.6K in Q4 2025.
  • 255 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2026.

Based on Los Angeles Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.